Abstract
Trypanosoma brucei prostaglandin F2alpha synthase is an aldo-ketoreductase that catalyzes the reduction of prostaglandin H2 to PGF2alpha in addition to that of 9,10-phenanthrenequinone. We report the crystal structure of TbPGFS.NADP+.citrate at 2.1 angstroms resolution. TbPGFS adopts a parallel (alpha/beta)8-barrel fold lacking the protrudent loops and possesses a hydrophobic core active site that contains a catalytic tetrad of tyrosine, lysine, histidine, and aspartate, which is highly conserved among AKRs. Site-directed mutagenesis of the catalytic tetrad residues revealed that a dyad of Lys77 and His110, and a triad of Tyr52, Lys77, and His110 are essential for the reduction of PGH2 and 9,10-PQ, respectively. Structural and kinetic analysis revealed that His110, acts as the general acid catalyst for PGH2 reduction and that Lys77 facilitates His110 protonation through a water molecule, while exerting an electrostatic repulsion against His110 that maintains the spatial arrangement which allows the formation of a hydrogen bond between His110 and C11 that carbonyl of PGH2. We also show Tyr52 acts as the general acid catalyst for 9,10-PQ reduction, and thus we not only elucidate the catalytic mechanism of a PGH2 reductase but also provide an insight into the catalytic specificity of AKRs.
Highlights
Trypanosoma brucei prostaglandin F2␣ synthase is an aldo-ketoreductase that catalyzes the reduction of prostaglandin H2 to PGF2␣ in addition to that of 9,10-phenanthrenequinone
TbPGFS adopts a parallel (␣/)8-barrel fold lacking the protrudent loops and possesses a hydrophobic core active site that contains a catalytic tetrad of tyrosine, lysine, histidine, and aspartate, which is highly conserved among AKRs
We show that Tyr52 acts as the general acid catalyst for 9,10-PQ reduction, and we elucidate the catalytic mechanism of a PGH2 reductase and provide an insight into the catalytic specificity of AKRs
Summary
Prostaglandin H2 Reductase Provides Insight into the Catalytic Mechanism of Aldo-ketoreductases*. Earlier structural and functional studies on AKRs have elucidated the catalytic mechanism of the oxidation/reduction reaction for physiological substrates such as monosaccharides (8 –10), steroid hormones [4], and aldehydes [1, 11]. These studies revealed that bacterial and mammalian AKRs catalyze the oxidation/reduction through a catalytic mechanism that involves a catalytic tetrad of aspartate, tyrosine, lysine, and histidine. We propose a catalytic mechanism by which a catalytic dyad of Lys and His110 in TbPGFS is involved in proton transfer to the 9,11-endoperoxide moiety of PGH2
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have